Simplex Castings Ltd Gets BSE Nod for ₹99.71 Crore Raise
Key highlights
- BSE granted Simplex Castings Ltd in-principle approval on November 3, 2026, for a ₹99.71 crore preferential issue at ₹105 per instrument.
- Simplex Castings allotted 10,53,312 equity shares at ₹105 each on November 12, 2026, raising ₹11.06 crore.
- The company allotted 7,26,809 warrants on November 12, with ₹1.91 crore received upfront and ₹7.63 crore of total potential warrant consideration.
- Warrant holders must pay the remaining ₹78.75 per warrant within 18 months to receive one equity share for each warrant.
powered by IRIS

Simplex Castings Ltd received BSE in-principle approval on November 3, 2026, for a ₹99.71 crore preferential fundraise priced at ₹105 per equity share or warrant. The company subsequently allotted 10,53,312 equity shares and 7,26,809 convertible warrants on November 12, representing a total potential consideration of about ₹18.69 crore.
Know Simplex Castings inside out
Results, valuation, peers and who's buying, in one view.
What approval did Simplex Castings receive from BSE?
Simplex Castings received BSE's in-principle approval on November 3, 2026, for a preferential issue of equity shares and warrants at ₹105 per instrument. The approved fundraising programme has a proposed size of ₹99.71 crore and covers 94.96 lakh direct and potential equity securities.
The issue price includes a face value of ₹2 per equity share and a premium of ₹103 per share. Company disclosures describe the proposed fundraising as comprising ₹10 crore of promoter participation and ₹89.71 crore of non-promoter participation. The capital is intended to support execution, according to the company's presentation on the preferential fundraise.
BSE's in-principle approval is a regulatory step that permits the company to proceed with the preferential issue in line with applicable listing and securities regulations. It does not, by itself, mean that the entire approved amount has been allotted or collected.
The approval followed the special resolution passed at the company's extraordinary general meeting on October 15, 2026. The allotments disclosed in November were approved by the board through circular resolutions and were reported under Regulation 30 of the Listing Obligations and Disclosure Requirements Regulations.
What did Simplex Castings allot on November 12?
Simplex Castings allotted 10,53,312 equity shares to 18 non-promoter allottees and 7,26,809 convertible warrants to 13 non-promoter allottees on November 12, 2026. Both the shares and warrants were issued at ₹105 each on a preferential basis.
The equity-share allotment raised ₹11.06 crore. The warrant issue has a total potential value of ₹7.63 crore if all warrants are converted into equity shares. Together, the newly allotted shares and potential shares from warrants represent aggregate consideration of about ₹18.69 crore.
Warrant subscribers paid 25% of the issue price, or ₹26.25 per warrant, upfront. This resulted in upfront warrant proceeds of ₹1.91 crore. The immediate cash raised through the share allotment and upfront warrant subscriptions was therefore about ₹12.97 crore.
The disclosed allotment followed an earlier preferential issue transaction on November 6, when Simplex Castings allotted 5,94,901 equity shares at ₹105 each, raising ₹6.25 crore. It also allotted 1,63,809 convertible warrants and received about ₹0.43 crore as the upfront subscription amount for those warrants.
How do the convertible warrants work?
Each warrant issued by Simplex Castings is convertible into one equity share on payment of the remaining ₹78.75 per warrant within 18 months of allotment. The upfront payment of ₹26.25 per warrant represents 25% of the ₹105 issue price.
If warrant holders exercise their conversion option and pay the balance amount, the company can receive the remaining 75% of the warrant consideration. The ₹7.63 crore warrant issue size is therefore a potential amount, while the ₹1.91 crore upfront payment is the amount received at the time of allotment.
The company has stated that warrants not exercised within the 18-month period will lapse. In that event, the upfront subscription amount paid by the warrant holder will be forfeited. No change in paid-up share capital arises from warrant allotment until conversion takes place.
The shares allotted and the equity shares that may arise from warrant conversion are subject to the lock-in requirements under the SEBI Issue of Capital and Disclosure Requirements framework. The newly allotted equity shares rank pari passu with the existing equity shares of the company.
Got a follow-up? Ask IRIS
What are the key dates and amounts in the preferential issue?
The preferential issue progressed from shareholder approval in October to BSE approval in early November and allotments during the month. The company has disclosed separate allotment events, which is important when comparing the approved ₹99.71 crore programme with cash received and securities actually allotted.
The reported November 12 allotment involves 31 non-promoter investors in total, consisting of 18 equity-share allottees and 13 warrant allottees. Among the named larger allottees in the disclosed details were NABS Equity, Venktesh Investment and Trading Co, Serene Alpha Capital Fund 1, and Dipali Devang Sheth.
The distinction between shares and warrants is material for investors. Equity shares increase the issued share capital immediately, whereas warrants create a possible future increase in equity capital if holders complete conversion within the stipulated period.
How does the preferential issue affect Simplex Castings investors?
The preferential allotment adds new equity shares to Simplex Castings' issued capital immediately and may add further shares if the warrants are converted. Existing shareholders should therefore consider both the current equity allotment and the full potential dilution from the warrant conversion when assessing the capital-structure effect.
At the same time, the transaction has brought immediate funds through equity issuance and the 25% upfront warrant subscription. The November 12 allotment alone generated about ₹12.97 crore in immediate proceeds, comprising ₹11.06 crore from shares and ₹1.91 crore from upfront warrant payments.
The proposed ₹99.71 crore issue remains larger than the individual allotments reported during November. The disclosures provide the price, allotment quantities, payment terms and conversion timeline, but do not state that the full approved issue amount has been raised through the reported November allotments.
For the broader market, preferential issues are a route through which listed companies can raise capital from identified investors rather than through a public offer. The terms in this case place the warrant conversion decision with investors, subject to payment of the outstanding ₹78.75 per warrant before the 18-month deadline.
Conclusion
Simplex Castings has secured BSE approval for a ₹99.71 crore preferential fundraising programme and has disclosed multiple allotments at ₹105 per share or warrant. The November 12 allotment added 10,53,312 equity shares, issued 7,26,809 warrants and produced immediate proceeds of about ₹12.97 crore, while the warrants carry further potential consideration upon conversion.
Investors should watch for further allotments under the approved programme, disclosures on the use of proceeds and warrant conversion activity over the 18-month exercise period. The key unresolved point is the extent to which the full ₹99.71 crore approved preferential issue will be completed through subsequent issuances and conversions.


